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On September 16, 2014, Judge Paul
Friedman of the U.S. District Court for the
District of Columbia issued a major decision
in Securities Industry and Financial Markets
Association et al. v. U.S. Commodity Futures
Trading Commission1 (hereinafter referred to
as “SIFMA v. CFTC”) regarding the validity
of the Interpretive Guidance and Policy
Statement issued by the U.S. Commodity
Futures Trading Commission (“CFTC”) on
July 26, 2013.2 This article will analyze this
court decision and will discuss its impact on
the CFTC’s Final Guidance.

Background
OTC derivatives3 represent an important
financial product in today’s global
marketplace. While virtually unknown to the
financial world just a few decades ago, their
CONTINUED ON PAGE 3
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growth began to explode in the 1990s. There was,
however, significant legal uncertainty4 then as to
whether an OTC derivative fell within the definition
of a futures contract and would therefore be subject
to the exclusive jurisdiction of the CFTC pursuant
to Section 2(a)(1)(A) of the Commodity Exchange
Act (“CEA”).5 This uncertainty grew from the
concern that, if such contracts were deemed to be
illegally traded off-exchange futures contracts, they
would be void ab initio, and losing parties could
simply walk away from their obligations under the
contracts. In an attempt to provide more clarity
and certainty, Congress provided the CFTC with
exemptive authority in the 1992 Futures Trading
Practices Act,6 and, as noted in the Conference
Report to the 1992 Act, Congress instructed the
Agency to use the provision “promptly.”7
The CFTC reacted to the 1992 Act with
the promulgation of Part 35 of Commission
Regulations8 in an initial attempt to provide certain
safe harbors to allow OTC derivatives not only to
avoid being subject to regulation by the CFTC, but
also to benefit from preemption from other federal
and state regulations due to the exclusive jurisdiction
provision of the CEA.9
While this administrative relief was welcomed,
it did not go far enough. Market participants
during the mid-to-late 1990s continued to clamor
for a legislative fix to the problem. In November
1999, the President’s Working Group issued a
report on OTC Derivatives, which contained a
specific recommendation to provide statutory
deregulation to the OTC derivatives markets.10 In
response, Congress enacted the Commodity Futures
Modernization Act of 2000 (“CFMA”).11 The
Plaintiffs in this case referenced the CFMA, citing:
“In passing the Commodity Futures
Modernization Act in 2000, Congress sided
with the proponents of deregulation and
barred the CFTC and the United States
Securities and Exchange Commission
(“SEC”) from regulating most derivative
swaps markets. The CFMA left the markets
for mostly derivative swaps ‘essentially
unregulated and unmonitored – effectively
dark – in most respects.’ And those markets
flourished until the 2008 financial crisis,
citing Inv. Co. Inst.”12
As the district court noted, OTC derivatives
flourished, reaching an estimated notional value
on a global basis between $500 to $650 trillion.13
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Certain OTC derivatives, however, were deemed to
have contributed to the 2008 financial crisis,14 in
particular, credit default swaps. In large part, as a
reaction to this, Congress enacted the Dodd-Frank
Wall Street Reform and Consumer Protection Act of
2010 (“Dodd-Frank Act”).15 Title VII of the DoddFrank Act16 created myriad new mandates relating
to OTC derivatives, which, among other things,
directly repealed much of the CFMA of 2000 that
applied to OTC derivatives, and represented a
massive revision in the federal oversight of OTC
derivatives regulation. 17
One of the areas of revision in OTC regulation—
and indeed, one of the most complex areas—relates
to the extraterritorial reach of the Dodd-Frank Act.
Just before the enactment of the Dodd-Frank Act,
the U.S. Supreme Court issued a significant decision
in Morrison v. National Australian Bank, which
restricted the extraterritorial applicability of Section
10b-5 of the Securities Exchange Act of 1934 by
barring federal lawsuits in the U.S. based upon
allegedly fraudulent securities transactions on nonU.S. securities exchanges.18 In the Dodd-Frank Act,
Congress reacted to the Morrison case by enacting
Section 722, which added a new Section 2(i) of the
CEA, stating that:
“The provisions of this chapter relating
to swaps that were enacted by the Wall
Street Transparency and Accountability Act
of 2010 (including any rule prescribed or
regulation promulgated under that Act),
shall not apply to activities outside the
United States unless those activities—
(1) have a direct and significant
connection with activities in, or effect
on, commerce of the United States; or
(2) contravene such rules or regulations
as the Commission may prescribe or as
are necessary or appropriate to prevent
the evasion of any provision of this
chapter that was enacted by the Wall
Street Transparency and Accountability
Act of 2010”.19
One of the primary arguments made by the
Plaintiffs in this case was that the CFTC (a) did
not properly interpret this section of the DoddFrank Act, and (b) exceeded its authority in issuing
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the Final Guidance. This article will analyze the
Plaintiffs’ allegations, the district court’s rulings
on their claims, and the impact of this decision on
future application and effect of the Final Guidance.
20

The District Court Case

The Plaintiffs were three large trade associations:
the Securities Industry and Financial Markets
Association (“SIFMA”); the International Swap
Dealers Association (“ISDA”); and the Institute of
International Bankers (“IIB”). The Complaint was
filed on December 4, 2013. An Amended Complaint
was filed on December 27, 2013. Collectively, the
pleadings alleged, in essence, that:
1.

The CFTC unlawfully circumvented the
requirements of the Administrative Procedure
Act and the CEA by characterizing its crossborder regulation as a guidance, and ignored the
CEA’s Section 19(a) cost-benefit requirements,

2.

The challenged OTC regulatory rules lack
independent regulatory effect “on their face,”
and

3.

The CFTC’s action was an arbitrary and
capricious interpretation of Section 2(i) of the
CEA.21

Both parties filed a Motion for Summary
Judgment, and Supplemental Briefs. The CFTC also
filed a Motion to Dismiss and a Memorandum of
Law, challenging the Complaint. Several amici briefs
were filed, including one from several current and
former Democratic Senators and Representatives.22

Summary of the Opinion

The Plaintiffs’ challenges to the Final Guidance
raised both procedural and substantive arguments.
Procedurally, Plaintiffs argued that the Final
Guidance was, in essence, a legislative rule and,
thus, the CFTC had failed to comply with the
Administrative Procedure Act’s (“APA”) notice and
comment rulemaking requirements; therefore, the
CFTC’s action is arbitrary and capricious. Plaintiffs
also argued that the CFTC failed to comply with the
CEA’s cost-benefit analysis. Substantively, Plaintiffs’
argument was that the CFTC misinterpreted Section
2(i) of the CEA, and thus exceeded its authority to
regulate non-U.S. swap dealers.
In his separate Order,23 Judge Friedman granted
in part and denied in part the CFTC’s Motion to
Dismiss and the Motions for Summary Judgment
of both Parties. In sum and substance, he ruled
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in favor of the CFTC with regard to one rule
by dismissing Plaintiffs’ claim as to the “trade
execution rule”24 based on a lack of standing, ruled
in favor of the CFTC as to the characterization of
its Final Guidance as a policy statement (and also
ruled that one four-page section of the document
constituted an interpretive rule), and ruled in favor
of the Plaintiffs’ argument that the CFTC had failed
to perform the required Section 19(a) cost-benefit
analyses on ten rules recently adopted by the CFTC
pursuant to Title VII (the “Title VII rules”) that had
extraterritorial effect.25 He declined, however, to
grant Plaintiffs’ motion to stay the effect of the rules,
stating that such a stay would be “unnecessarily
disruptive,” and that “[a]ny deficiency in the Title
VII Rules is not no so ‘serious’ as to favor vacatur .
. . .”26 Accordingly, the court remanded back to the
CFTC only those rules that required a cost-benefit
analysis, namely:
1.

the Real-Time Public Reporting of Swap
Transaction Date Rule;

2.

the Recordkeeping and Reporting Requirements
(to SDRs) Rule;

3.

the Registration of Swap Dealers and Major
Swap Participants Rule;

4.

the Swap Dealer and Major Swap Participant
Recordkeeping, Reporting and Duties Rules;

5.

the FCM and IB Conflicts of Interest Rules;

6.

the Chief Compliance Officer Rules for Swap
Dealers, Major Swap Participants and FCMs;
and

7.

the Definitions of Swap Dealers, Security-Based
Swap Dealers, Major Swap Participants, the
Major Security-Based Swap Participants and
Eligible Contract Participants Rules.27

A. Standing and Ripeness Issues

In his opinion, Judge Friedman first dealt with
the standing and ripeness issues. With regard to
standing, he addressed whether the Plaintiffs,
three large trade associations, had standing under
Article III, to challenge the Final Guidance and the
underlying CFTC regulations established under Title
VII. To demonstrate standing, a plaintiff must show:
(1) that is has suffered an “injury in fact”; (2) that
the injury is traceable to the challenged action of the
defendant; and (3) that it is likely that the injury will
be addressed in a favorable decision.”28 In this case,
a trade association, on its own behalf, does not have
such standing but may have standing (a) if one of
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its members would have had standing to bring this
challenge in its own right, (b) the interest it seeks
to protect is germane to its purpose, and (c) neither
the claim asserted nor the relief requested requires
the member to participate in the lawsuit.29 The court
held that the second and third prongs clearly applied
in this case.30 It therefore focused on the first prong
and noted:
“.… the plaintiff associations must identify
for each challenged Title VII Rule at least
one member or one of their associations
that is regulated or directly harmed by that
Rule’s extraterritorial application. For the
limited purpose of its standing analysis,
the Court must assume that the plaintiffs
are correct that the Cross-Border Action is
a binding legislative rule carrying the force
of law.”31
In support of their claim, several senior executives
at the member firms submitted affidavits and
declarations that confirmed that many of their
firms were affected by the extraterritorial aspects
of the Final Guidance.32 The court concluded that
the Plaintiffs did have standing to challenge the
extraterritorial aspects of the Final Guidance and
several of the transaction-level regulations that had
been promulgated by the CFTC under Title VII33
but not the Trade Execution Rule.34 The Court
further held that, as to the member firms of the
Plaintiffs that were based in the U.S., with respect
to the entity-level Title VII rules, such as the Entity
Definition rule, the Swap Entity Registration rule,
the Risk Management rule, the Chief Compliance
Officer rule, the SDR Reporting rule, the Historical
SDR Reporting rule, and the Large Trading Rule,
the U.S. member firms of the Plaintiffs did not
have standing35 whereas the member firms of the
Plaintiffs that were based outside the U.S. (e.g.,
their foreign affiliates, such as their U.K affiliates),
did have standing to challenge the extraterritorial
aspects of the Final Guidance.36 Therefore, except
for the Trade Execution Rule, the court held that
the Plaintiffs had standing to bring this challenge.37
As to ripeness, Judge Friedman ruled that the
procedural claims brought by the Plaintiffs are
“clearly ripe for review”38 because they require
“no further factual or contextual development”
of whether the CFTC’s action was legislative,
interpretive, or a statement of policy. The district
court stated that the substantive claims “hinge
on the CFTC’s potential future application of the
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Cross-Border Action to a variety of future factual
situations”.39 The court noted this was a difficult
question, but determined that it need not be
addressed now. Specifically, Judge Friedman held
that
“Here, the Court need not look so far away
as a companion case or even consult Circuit
precedent. For the Court’s consideration of
plaintiff’s ripe procedural claims reveals
that the Cross-Border Action is not a ‘final
agency action’ subject to review under
the APA. [ . . .]. This conclusion requires
judgment for the CFTC as to all of the
plaintiffs’ pre-enforcement challenges to
the Cross-Border Act—both procedural
and substantive.” (emphasis added)40
Accordingly, the Court determined that all issues
before it were ripe for judicial review.

B. The Final Guidance

On July 12, 2012, the CFTC issued a proposed
interpretative guidance and policy statement
regarding the cross-border application of Title
VII, including new Section 2(i) of the CEA.41 The
Proposed Guidance was very controversial, resulting
in approximately 300 comment letters, including
several from non-U.S. governmental regulators who
criticized the attempted broad regulatory reach of
the CFTC on non-U.S. firms as proposed in the
Proposed Guidance.42 The Proposed Guidance dealt
with a number of issues, including, among other
things, a very broad definition of a “U.S. Person,”
that, as initially proposed, would require many nonU.S. Swap Dealers to be required to registered as a
“swap dealer” with the CFTC. The CFTC’s Global
Markets Advisory Committee (“GMAC”) held
hearings in November 2012, in which a number
of U.S. industry leaders and non-U.S. government
leaders commented on the Proposed Guidance. On
January 7, 2013, the CFTC issued further proposed
guidance on certain provisions set forth in the initial
Proposed Guidance.43 Several new comment letters
followed. On July 22, 2013, the CFTC issued an
Exemptive Order that provided certain temporary
relief from some of the Swap Dealer regulations that
had been promulgated to date by the CFTC.44 One
day later, the CFTC adopted the Final Guidance.45
While hardly satisfied with the Final Guidance,
market participants, in the main, worked diligently
to attempt to comply with the numerous new rules
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imposed upon them, not only in the U.S., but in
other jurisdictions around the world, particularly
the European Union. It is significant to note that,
in issuing the Final Guidance and its complicated
definition of “U.S. Person,” there was no
“locational requirement” included with regard to
foreign branches of foreign entities that transacted
swaps business in the U.S. The key issue was thus
whether a foreign branch office or affiliate of a
U.S. firm should or should not be deemed to be a
“U.S. Person” or be required to have their swap
positions aggregated with those of its U.S. affiliates
for purposes of meeting the $8.0 billion de minimus
test.46
Subsequently, on November 14, 2013, the
CFTC’s Division of Swap Dealer and Intermediary
Oversight (“DSIO”) published an advisory, which
essentially reversed this position. In an interpretation
of Footnote 513 in the Final Guidance,47, 48 the
staff letter provided that such activity would now
constitute conduct by a “U.S. Person,” such that
swaps activity undertaken by that person (e.g., the
non-U.S. affiliates) would be required to comply
with regulations promulgated by the CFTC.49 This
Advisory was quite controversial, to put it mildly.
Indeed, the CFTC, recognizing the difficulties created
by this action, in effect backed away from this
position in January 2013, and issued a request for
comments on the issue, and a temporary reprieve, to
September 15, 2014 (later extended for some rules
to December 2014) of the application of the DoddFrank Act rules.50 It is noteworthy that the opinion
in this case was issued prior to that compliance
deadline. The consequences will be discussed below.

The District Court Opinion

First, the opinion provided an excellent summary
of the regulatory history regarding how OTC
derivatives were not regulated prior to 2010, and
how they became subject to extensive regulation
following the enactment of the Dodd-Frank Act.
As part of the Dodd-Frank Act, Congress ordered
that 398 new regulations needed to be promulgated
by various federal financial regulatory agencies,
including 60 new regulations by the CFTC. As
noted above, in this opinion Judge Friedman
addressed several of these new CFTC regulations
involving OTC derivatives in addition to the Final
Guidance, and determined that the CFTC had
not acknowledged the cost-benefit analyses of the
extraterritorial applications of several of these new
regulations.51
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Interpretation of Section 2(i) of
the CEA

The court held that the CFTC’s interpretation of
Section 2(i) as a “clear expression of congressional
intent that the swaps provisions of Title VII of the
Dodd-Frank Act apply to activities beyond the
borders of the United States when circumstances are
present” was a correct one. Judge Friedman then
stated:
“The Cross-Border Action goes on to
construe the word ‘direct’ in Section 2(i)
(1) to require only ‘a reasonable proximate
causal nexus’ and not ‘foreseeability,
substantiality or immediacy.’” In making
this determination, the Cross-Border Action
adopts the position of the Department
of Justice Antitrust Division with respect
to the meaning of the same term in the
Foreign Trade Antitrust Improvements
Act, 15 U.S.C. 6a, which had been recently
adopted by the Seventh Circuit sitting en
banc in Minn-Chem Inc. v. Agrium Inc. 683
F. 3d 845 (7th Circuit 2012).”52
Judge Friedman added:
“The Cross-Border Action also rejects any
interpretation of Section 2(i)(1) that would
‘require a transaction-by-transaction basis
determination that a specific swap outside
the United States’ has the jurisdictional
requisite ‘connection with activities in, or
effect on, commerce in the United States
. . . .’”53
“The Cross-Border Action distinguishes
itself from a ‘binding rule’ that ‘would
state with precision when particular
requirements do and do not apply to
particular situations,’ Instead, the CrossBorder Action is ‘a statement of the
[CFTC]’s general policy regarding cross—
border activities and allows for flexibility
in application to various situations . . . .”54
The Opinion discussed various aspects of the
Final Guidance, in particular, its interpretation of a
“U.S. person,” its aggregation analysis in connection
with the de minimus quantity of swap-dealing

© 2014 THOMSON REUTERS

Futures & Derivatives Law Report

October 2014 n Volume 34 n Issue 9

transactions, the categorization of certain Title VII
rules as either “entity-level” or “transaction-level,”
and the substituted compliance treatment.
The Opinion also analyzed the doctrine of
“legislative rule” vs. “interpretive rules” and stated
that, distinguishing between the two, the court
would look to whether a “substantive regulatory
change” was effected. To evaluate whether any such
change has occurred, the court applied a four-factor
test that considers:

action, let alone in enough enforcement
actions and with enough consistency
to signal that the agency considers it a
binding rule.”61

“(1) whether in the absence of the rule
there would not be an adequate legislative
basis for enforcement action or other
agency action to confer benefits or ensure
the performance of duties, (2) whether the
agency has published the rule in the Code
of Federal Regulations, (3) whether the
agency has explicitly invoked its general
legislative authority, [and] (4) whether the
rule effectively amends a prior legislative
rule.”55

The court addressed the challenge brought
by the Plaintiffs that the Title VII rules issued to
date by the CFTC did not adequately address the
extraterritorial aspect of the respective rules, in
particular, that the Title VII rules cannot apply
extraterritorially because, in essence, they do not
take into consideration the plain language of Section
2(i). The court held that the plain text of Section 2(i)
“clearly expresses Congress’ ‘affirmative intention’
to give extraterritorial effect to Title VII’s statutory
requirements as well as to the Title VII rules
prescribed by the CFTC”.63 The court also held that
the CFTC is not required to address the scope of
each rule’s extraterritorial application.64
The court did agree that the CFTC was required,
but failed to consider the costs and benefits of some
of the Title VII rules. The court held that “the CEA
requires the CFTC before promulgating a regulation
to consider the costs and benefits of its actions.65 In
particular, the CFTC has a duty to consider the costs
and benefits of a given Title VII rule’s extraterritorial
application.66
The court then ruled that it had the authority to
remand these Title VII rules back to the CFTC but
without vacatur.67 However, the court also held that
the CFTC need only consider the “substance” of the
Title VII rules, not their “scope”, in their review.68

“Generally, if any of these prongs is
satisfied, the rule is legislative rather than
interpretative.”56
The court found none of the prongs were present
in this case, and therefore concluded that the CrossBorder Action is binding on neither the CFTC nor
on market participants. Indeed, the court stated
specifically that the Cross-Border Action does not
“purport to carry the force of law.”57 The Guidance,
the Court confirmed, merely “announces the
CFTC’s ‘general policy regarding cross-border swap
activities and allows for flexibility in application
to various situations “58 The court relied heavily
on numerous references contained in the Final
Guidance whereby the CFTC qualified “its policy
positions with the conditional terms ‘generally’ and
‘ordinarily.’”59 The court then stated:
“The Court therefore is satisfied that no
CFTC staff member or market participant
could, after consulting the Cross-Border
Action in its entirety, reasonably construe
it as setting forth binding norms.”60
The court added:
“The CFTC has yet to rely on the CrossBorder Action in a single enforcement
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“The important fact in this case is that
plaintiffs’ members remain completely
‘free to ignore’ the Cross-Border Action’s
‘writing on the wall.’”62 (emphasis added)

Conclusion

So, if the Final Guidance has “no binding effect,”
how will it be interpreted in eventual enforcement
actions? Certainly, future defendants will argue that
it has no purpose or relevance, and just as certainly
the CFTC will rely on it as a “best practice”
guideline. Now labeled by a federal district court
as a mere interpretative notice, however, it appears
that this opinion certainly lessens the strength of the
document as it applies to future usage by the CFTC
in administrative or injunctive actions. In addition,
it would appear that the “Footnote 513” imbroglio
becomes less of a burning issue, and that firms
should be less concerned about compliance with the
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infamous staff advisory come midnight December
2014.
The opinion also raises other provocative
questions. For example, inasmuch as other countries
have taken some adverse actions against U.S. swap
dealers, does this now make the Final Guidance an
albatross for the CFTC here in the U.S?
The court took certain actions in favor of the
CFTC and granted and dismissed in part several
of the challenges brought by the Plaintiffs. It will
be interesting to see whether either or both parties
will appeal Judge Friedman’s decision. Equally
as importantly, it may be a while before we really
know the true meaning and effect of this decision.
What will the CFTC do with respect to the
remand of the Title VII rules as required by this
court decision? How quickly will they react to the
adjuration to undertake cost-benefit analyses, and
will those outcomes then be challenged? Query, is
there an internal contradiction in the opinion, if the
Court is requiring the CFTC on remand to address
the cost-benefit analysis of the Final Guidance on
the extraterritoriality of certain Title VII rules, when
the court did not interpret the Final Guidance as a
rule, inasmuch as Section 19(a) does not apply to an
interpretative notice issued by the CFTC?
And what will the CFTC do now? At a recent
hearing held on September 17, 2014, one day
after the opinion was issued, Timothy Massad, the
new CFTC Chair, noted that: “the importance of
international harmonization cannot be understated”.
Does this comment, and others like it, signal a new
wind—and a welcome one—blowing at the CFTC
in terms of true global comity with regard to OTC
regulation?69 Certainly, the Chairman’s thoughtful,
deliberative, and well-analyzed actions since taking
office would hopefully indicate that things are
moving in the right direction. One day later, on
September 18, 2014, the Financial Stability Board
issued a report to the G20 Finance Ministers and
Central Bank Governors that addressed whether
any country had deferred its regulatory approach
to another country’s regulatory regime.70 In essence,
the FSB opined that few countries had deferred
any of their own OTC derivatives rulemakings to
other countries. It did mention the Comparability
Determinations issued by the CFTC in December
201371 but held that, overall, the G20 countries
have not cooperated among themselves as they had
agreed to at the G-20 Summit held in Pittsburgh, PA
in September 2009.
Finally, given the criticism that erupted when the
Proposed Guidance was issued and even with the
Final Guidance, this decision in SIFMA v. CFTC
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may give the CFTC the impetus to revisit the Final
Guidance and apply a more harmonized regulatory
approach regarding the extraterritorial applications
of its various rules that have been promulgated as a
result of the Dodd-Frank Act.
The OTC derivatives industry is indeed a global
one. Global regulatory harmonization is at a critical
junction, and there is a signal opportunity for
the CFTC to take advantage of this grace period,
and resolve this thorniest of issues facing our
international markets.
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